As the COVID‐19 pandemic has largely increased the utilization of telehealth, mobile mental
health technologies–such as smartphone apps, virtual reality, chatbots, and social media …

Background Lithium has been used clinically for 70 years, mainly to treat bipolar disorder.
Competing treatments and exaggerated impressions about complexity and risks of lithium …

Abstract The ongoing Coronavirus Disease (COVID-19) pandemic has so far affected more
than 500 million people. Lingering fatigue and cognitive difficulties are key concerns …

This Review discusses crucial areas related to the identification, clinical presentation,
course, and therapeutic management of bipolar disorder, a major psychiatric illness. Bipolar …

Objective: Currently, the diagnosis in bipolar disorder relies on patient information and
careful clinical evaluations and judgements with a lack of objective tests. Core clinical …

Objectives Cognitive impairment affects many patients with bipolar disorder (BD), and
treatments with replicated pro‐cognitive effects are lacking. This study aimed to assess the …

The search for biomarkers has been a leading endeavor in biological psychiatry. To analyze
its evolution over the years, we performed a systematic review to evaluate (a) the most …

There is a pressing need for measures of real-life cognitive functioning in patients with mood
or psychotic disorders in clinical settings and treatment trials targeting cognition. We …

Abstract Objectives The International Society for Bipolar Disorders Big Data Task Force
assembled leading researchers in the field of bipolar disorder (BD), machine learning, and …

Objective The prevalence of metabolic syndrome and insulin resistance is twice as high in
patients with bipolar disorder compared with the general population, and possibly …